27 Feb 2019
We are delighted to share the news that Dr Ronald Cohn, the head of the DRF’s Scientific Advisory Board, has been appointed President and CEO of the Hospital for Sick Children in Toronto, Canada (known as ‘Sick Kids’), effective 1 May 2019. Dr Cohn...
7 Feb 2019
Solid Biosciences has announced preliminary data from its IGNITE DMD gene therapy clinical trial. The Duchenne Research Fund is proud to have helped seed fund Solid’s gene therapy program together with Duchenne UK and Joining Jack, with a joint investment of $5...
3 Dec 2018
We are pleased to share a report from Great Ormond Street Hospital (GOSH) about the positive impact of the clinical staff posts that we helped to fund at the hospital as part of the DMD Hub, together with Duchenne UK, Harrison’s Fund and the Great Ormond Street...
23 Nov 2018
The Duchenne Research Fund’s co-founders Kerry and Doron Rosenfeld are honoured to have received the Prime Minister’s Points of Light award. The initiative recognises “outstanding individual volunteers – people who are making a change in their...
30 Sep 2018
Thank you to our fundariser Lauren Halsey who did a skydive in memory of her brother, who had Duchenne. We’re so grateful for the funds she raised, which will go towards our vital projects. Thank you! Click here to see our fundraising...
31 Jul 2018
The Duchenne Research Fund has awarded a £200,000 grant to the team at the Hospital for Sick Children in Toronto, Canada (‘Sick Kids’), who are working on using CRISPR/Cas9 technology to correct duplication mutations for Duchenne. Sick Kids’ incoming President and CEO...
30 Jul 2018
Congratulations to the #TeamDRF cyclists who took on the Prudential RideLondon-Surrey on Sunday 29 July in treacherous conditions and raised more than £30,000 to help combat Duchenne. The annual ride is one of Europe’s biggest sporting events, with more than 25,000...
26 Jun 2018
We are pleased to share an update from ReveraGen about its Vamorolone clinical trial. Vamorolone is an alternative treatment to existing steroids that aims to maximise the benefits while reducing the side effects. In 2014, The Duchenne Research Fund helped fund the...
25 Jun 2018
Five years ago we identified gene therapy as a viable treatment for Duchenne. Today we are reflecting on the exciting and inspiring events of the past week in the gene therapy arena which are now bringing hope and cautious optimism to the Duchenne community. We have...
18 Jun 2018
Message from Solid Biosciences: “We’re pleased to share with you that the FDA has lifted the clinical hold on IGNITE DMD, our clinical trial investigating SGT-001 as a potential treatment for Duchenne muscular dystrophy (DMD). SGT-001 is a microdystrophin gene...